Paper393891
Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review.
Maack T and 4 others. Kidney Int, 1979. Cited by 783 papers, by iCite.
Cite this record
ConductScience Library. Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Papers, record 393891. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/393891
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Proteins | Major topic |
| Kidney | Major topic |
| Animals | |
| Biological Transport | |
| Dogs | |
| Fishes | |
| Glomerular Filtration Rate | |
| Gonadotropins | |
| Humans | |
| In Vitro Techniques | |
| Kidney Glomerulus | |
| Kidney Tubules | |
| Mice | |
| Proteins | |
| Proteinuria | |
| Rabbits | |
| Rats |
Source PubMed
Cited by170
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 783 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983320 | Disease states associated with lysozymuria, along with histological correlations. | BMC Nephrol | 2026 | https://conductscience.org/library/papers/42983320 | PubMed |
| 42699873 | A chimeric, half-life extended lysin with a unique mode of action. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42699873 | PubMed |
| 42653122 | Beneficial Hepatokines in MASLD/MASH: Therapeutic Potentials and Drug Delivery Challenges. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653122 | PubMed |
| 42511953 | Renal Functional Reserve-Informed Personalized Renoprotection in Chronic Kidney Disease: A Proposed Extension of the KDIGO CGA Framework. | Biomedicines | 2026 | https://conductscience.org/library/papers/42511953 | PubMed |
| 41942053 | Therapeutic peptides and proteins: Status and developments in drug delivery. | J Control Release | 2026 | https://conductscience.org/library/papers/41942053 | PubMed |
| 41803103 | Heterogeneity in lysosomal dynamics and metabolic functions along the kidney proximal tubule. | Nat Commun | 2026 | https://conductscience.org/library/papers/41803103 | PubMed |
| 40868160 | Uncommon Factors Leading to Nephrotic Syndrome. | Biomedicines | 2025 | https://conductscience.org/library/papers/40868160 | PubMed |
| 39898971 | Phage-derived proteins: Advancing food safety through biocontrol and detection of foodborne pathogens. | Compr Rev Food Sci Food Saf | 2025 | https://conductscience.org/library/papers/39898971 | PubMed |
| 39762367 | Protein handling in kidney tubules. | Nat Rev Nephrol | 2025 | https://conductscience.org/library/papers/39762367 | PubMed |
| 39610876 | Obstacles, research progress, and prospects of oral delivery of bioactive peptides: a comprehensive review. | Front Nutr | 2024 | https://conductscience.org/library/papers/39610876 | PubMed |
| 38184374 | Unveiling cytokine charge disparity as a potential mechanism for immune regulation. | Cytokine Growth Factor Rev | 2024 | https://conductscience.org/library/papers/38184374 | PubMed |
| 38161981 | The negative impact of levothyroxine treatment on urinary luteinizing hormone measurements in pediatric patients with thyroid disease. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/38161981 | PubMed |
| 37999893 | Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases. | BioDrugs | 2024 | https://conductscience.org/library/papers/37999893 | PubMed |
| 37885887 | Kappa free light chains index in multiple sclerosis very long-term prognosis. | Front Immunol | 2023 | https://conductscience.org/library/papers/37885887 | PubMed |
| 37354999 | Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies. | Biotechnol Adv | 2023 | https://conductscience.org/library/papers/37354999 | PubMed |
| 36979933 | Urinary ACE Phenotyping as a Research and Diagnostic Tool: Identification of Sex-Dependent ACE Immunoreactivity. | Biomedicines | 2023 | https://conductscience.org/library/papers/36979933 | PubMed |
| 36826285 | Advanced Drug Delivery Systems for Renal Disorders. | Gels | 2023 | https://conductscience.org/library/papers/36826285 | PubMed |
| 36387592 | Advances in the stability challenges of bioactive peptides and improvement strategies. | Curr Res Food Sci | 2022 | https://conductscience.org/library/papers/36387592 | PubMed |
| 36175561 | Spatiotemporal organisation of protein processing in the kidney. | Nat Commun | 2022 | https://conductscience.org/library/papers/36175561 | PubMed |
| 36142600 | Molecular Biosimilarity-An AI-Driven Paradigm Shift. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142600 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/393891
GET https://conductscience.org/api/papers/v1/393891/cited_by?page=2